Liver Diseases  >>  Ximency (daclatasvir/asunaprevir/beclabuvir)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ximency (daclatasvir/asunaprevir/beclabuvir) / BMS
HEPCOG-II, NCT02292966: Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism

Withdrawn
4
0
RoW
DCV/ASV/BCV, Daclatasvir, Asunaprevir, Beclabuvir
Kirby Institute, Bristol-Myers Squibb
Hepatitis C, Chronic
06/16
06/16

Download Options